• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管性血友病:诊断策略与治疗选择

von Willebrand Disease: Diagnostic Strategies and Treatment Options.

作者信息

Ng Christopher J, Di Paola Jorge

机构信息

Department of Pediatrics, University of Colorado, Children's Hospital Colorado, 12800 East 19th Avenue, Research Center 1 North, MS 8302, Aurora, CO 80111, USA.

Department of Pediatrics, University of Colorado, Children's Hospital Colorado, 12800 East 19th Avenue, Research Center 1 North, MS 8302, Aurora, CO 80111, USA.

出版信息

Pediatr Clin North Am. 2018 Jun;65(3):527-541. doi: 10.1016/j.pcl.2018.02.004.

DOI:10.1016/j.pcl.2018.02.004
PMID:29803281
Abstract

von Willebrand disease (VWD) is one of the most common inherited bleeding disorders. Since its first description in 1926, the diagnosis and management of VWD has significantly improved due to increasing scientific knowledge of the genetics and biology of von Willebrand factor (VWF). This article reviews the molecular structure and function of VWF as well as the clinical symptoms, laboratory-based diagnostic workup, and classification schema for VWD. It highlights current treatment options and state-of-the art research in VWF and VWD.

摘要

血管性血友病(VWD)是最常见的遗传性出血性疾病之一。自1926年首次被描述以来,由于对血管性血友病因子(VWF)的遗传学和生物学的科学认识不断增加,VWD的诊断和管理有了显著改善。本文综述了VWF的分子结构和功能,以及VWD的临床症状、基于实验室的诊断检查和分类方案。它重点介绍了VWF和VWD目前的治疗选择以及最新研究进展。

相似文献

1
von Willebrand Disease: Diagnostic Strategies and Treatment Options.血管性血友病:诊断策略与治疗选择
Pediatr Clin North Am. 2018 Jun;65(3):527-541. doi: 10.1016/j.pcl.2018.02.004.
2
von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).血管性血友病(VWD):基于证据的诊断和管理指南,美国国立心肺血液研究所(NHLBI)专家小组报告
Haemophilia. 2008 Mar;14(2):171-232. doi: 10.1111/j.1365-2516.2007.01643.x.
3
von Willebrand disease: clinical and laboratory lessons learned from the large von Willebrand disease studies.血管性血友病:大型血管性血友病研究中获得的临床和实验室经验教训。
Am J Hematol. 2012 May;87 Suppl 1(0 1):S4-11. doi: 10.1002/ajh.23142. Epub 2012 Mar 3.
4
Management of inherited von Willebrand disease in 2007.2007年遗传性血管性血友病的管理
Ann Med. 2007;39(5):346-58. doi: 10.1080/07853890701513738.
5
Laboratory identification of von Willebrand disease: technical and scientific perspectives.血管性血友病的实验室诊断:技术与科学视角
Semin Thromb Hemost. 2006 Jul;32(5):456-71. doi: 10.1055/s-2006-947859.
6
Type 1 von Willebrand disease: application of emerging data to clinical practice.1型血管性血友病:新兴数据在临床实践中的应用
Haemophilia. 2008 Jul;14(4):685-96. doi: 10.1111/j.1365-2516.2008.01757.x. Epub 2008 May 23.
7
Epidemiology, diagnosis, and management of von Willebrand disease in India.印度血管性血友病的流行病学、诊断和治疗。
Semin Thromb Hemost. 2011 Jul;37(5):595-601. doi: 10.1055/s-0031-1281048. Epub 2011 Nov 18.
8
Acquired von Willebrand disease.获得性血管性血友病
Mayo Clin Proc. 2002 Feb;77(2):181-7. doi: 10.4065/77.2.181.
9
Von Willebrand's disease: case report and review of literature.血管性血友病:病例报告及文献综述
Pan Afr Med J. 2017 Jun 29;27:147. doi: 10.11604/pamj.2017.27.147.12248. eCollection 2017.
10
Monitoring Therapy during Treatment of von Willebrand Disease.血管性血友病治疗期间的治疗监测
Semin Thromb Hemost. 2017 Apr;43(3):338-354. doi: 10.1055/s-0036-1585080. Epub 2016 Jul 29.

引用本文的文献

1
First Clinical Nutrition Outpatient Consultation: A Review of Basic Principles in Nutritional Care of Adults with Hematologic Disease.首次临床营养门诊咨询:成人血液疾病营养照护基本原则回顾。
ScientificWorldJournal. 2023 Sep 21;2023:9303798. doi: 10.1155/2023/9303798. eCollection 2023.
2
Desmopressin as a hemostatic and blood sparing agent in bleeding disorders.去氨加压素在出血性疾病中的止血和节血作用。
Eur J Haematol. 2023 May;110(5):470-479. doi: 10.1111/ejh.13930. Epub 2023 Feb 12.